The selection coincides with Bar-Ilan’s 70th anniversary, placing Witkoff among a small group of world leaders previously recognized by the university.

CAR-T therapy uses a patient’s own immune cells, genetically modified to fight cancer.

The model was tested using wildfire data from 2021 and, according to the research team, showed an accuracy rate of over 90%.

The study identified airflow as a critical factor in navigational ability.